Kamada (KMDA) Other Non Operating Income (2016 - 2026)
Kamada (KMDA) reported Other Non Operating Income of -$261000.0 for Q1 2026, down 203.98% on a YoY basis from $251000.0 in Q1 2025, and up 35.56% quarter-over-quarter from -$405000.0 in Q4 2025.
Kamada (KMDA) Other Non Operating Income (2016 - 2026) Analysis & Trends
Kamada has reported Other Non Operating Income for 10 years, with the latest figure at -$261000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 203.98% year-over-year to -$261000.0; the trailing twelve-month figure through Mar 2026 stood at -$709974.0 (down 349.89% YoY), and the FY2025 full-year result was -$1.2 million, down 1145.74% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$261000.0, up from -$405000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $553000.0 in Q3 2023, with the low at -$671000.0 in Q4 2023.
- Historically, Other Non Operating Income has averaged -$41439.4 across 5 years, with a median of $151.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Non Operating Income surged 339163.8% — and 2025, when it plunged 609.95%.
- Kamada's Other Non Operating Income stood at -$458000.0 in 2022, then tumbled by 46.51% to -$671000.0 in 2023, then jumped by 47.99% to -$349000.0 in 2024, then fell by 16.05% to -$405000.0 in 2025, then soared by 35.56% to -$261000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$261000.0 (Q1 2026), -$405000.0 (Q4 2025), and -$43000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -261,000.00 |
| Dec 31, 2025 | -405,000.00 |
| Sep 30, 2025 | -43,000.00 |
| Jun 30, 2025 | -974.00 |
| Mar 31, 2025 | 251,000.00 |
| Dec 31, 2024 | -349,000.00 |
| Sep 30, 2024 | -60,000.00 |
| Jun 30, 2024 | 191.00 |
| Mar 31, 2024 | 124,000.00 |
| Dec 31, 2023 | -671,000.00 |
| Sep 30, 2023 | 553,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 151.00 |
| Dec 31, 2022 | -458,000.00 |
| Sep 30, 2022 | 163.00 |
| Jun 30, 2022 | 424,000.00 |
| Mar 31, 2022 | 169,000.00 |
| Dec 31, 2021 | -281,000.00 |
| Sep 30, 2021 | -48,000.00 |
| Jun 30, 2021 | -145,000.00 |